Moreover, we examined the correlation between CTHRC1 expression and immunotherapy markers, including CD274, PDCD1, CTLA4, and LAG3 in colon cancer, thyroid cancer, and melanoma. This evidence concerns the gene CTLA4 and malignant colon neoplasm.